ADMA Biologics, Inc. (NASDAQ:ADMA), announced that the Company has been recognized as one of New Jersey’s “100 Best Places to Work 2016” by the Best Companies Group, a company dedicated to identifying and recognizing places of employment that are leading the way in defining the employee experience, and NJBIZ, a leading New Jersey-focused weekly business news publication.
ADMA Biologics, Inc. (NASDAQ:ADMA) belongs to Healthcare sector. Its weekly performance is 5.56%. On last trading day company shares ended up at $4.75.
Zacks Investment Research restated their outperform rating on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ) in a research note published on Friday.
Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) shares moved down -5.34% in last trading session and ended the day at $5.67. Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) quarterly performance is -19.80%.
Armada Hoffler Properties, Inc. (NYSE:AHH) announced that its Board of Directors declared a cash dividend of $0.18 per common share for the first quarter of 2016, representing a 5.9% increase over the prior quarter’s cash dividend. The first quarter dividend will be payable in cash on April 7, 2016 to stockholders of record on March 30, 2016.
On 29 February, Armada Hoffler Properties, Inc. (NYSE:AHH) shares moved down -0.56% and was closed at $10.63. AHH EPS growth in last 5 year was -28.70%. Armada Hoffler Properties, Inc. (NYSE:AHH) year to date (YTD) performance is 1.43%.
MVC Capital, Inc. (NYSE:MVC) ended the last trading day at $7.18. Company weekly volatility is calculated as 2.32% and price to cash ratio as 7.37. MVC Capital, Inc. (NYSE:MVC) showed a weekly performance of 2.72%.
ResMed (NYSE:RMD), announced a definitive agreement to acquire privately held Brightree®, a leader in business management and clinical software applications for the post-acute care industry. This acquisition adds to ResMed’s global leadership in connected healthcare solutions.
ResMed Inc. (NYSE:RMD) shares moved down -1.44% in last trading session and ended the day at $56.91. RMD Gross Margin is 58.30% and its return on assets is 15.60%. ResMed Inc. (NYSE:RMD) quarterly performance is -3.91%.